Frequency of Ventilator Associated Pneumonia (VAP) in Mechanically Ventilated ICU Patients Using the AnapnoGuard System

Hospitech Respiration1 site in 1 country161 target enrollmentDecember 2010

ConditionsVentilator Associated Pneumonia

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Ventilator Associated Pneumonia
Sponsor: Hospitech Respiration
Enrollment: 161
Locations: 1
Primary Endpoint: VAP occurence
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Ventilator Associated Pneumonia (VAP) is a common complication experienced by mechanically ventilated patients and within the framework of Respiratory Intensive Care Units. The AnapnoGuard system, developed by Hospitech Respiration Ltd. is a ventilation guard system that includes a number of unique characteristics. This study was designed to test the frequency VAP in mechanically ventilated ICU patients using the AnapnoGuard System.

Registry

clinicaltrials.gov

Start Date

December 2010

End Date

December 2015

Last Updated

10 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Hospitech Respiration

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•ICU patients;
•Patient was connected to AnapnoGuard system up to six hours from intubation;
•Age - above 18.

Exclusion Criteria

•Pneumonia;
•Aspiration Pneumonia;
•Chronic or Severe Pneumonia;
•Chronic Obstructive Pulmonary Disease (COPD) requiring permanent home-based antibiotic treatment;
•Interstitial Lung Disease (ILD);
•Post Lung Transplant State;
•Immunosuppression.
•Patients ventilated in prone position
•Patient who was ventilated 3 months prior to being enrolled in the study
•Pregnant women